News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cellectis: 2012 Financial Results



4/30/2013 6:40:06 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Regulatory News:

Cellectis (Paris:ALCLS) (Alternext: ALCLS), the global genome engineering specialist, presented its consolidated financial statements for the 2012 fiscal year, approved for publication by the Board of Directors at their meeting today.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
Cellectis
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES